News Headline Summary

Negative for Sarepta Pharmaceuticals (SRPT) as competitor gets orphan for Duchenne Muscular Dystrophy

Reaction details:

- Sarepta shares moved lower in reaction to the news before bouncing; trades USD 25.26 last.

Print 16:05, 24 Jan 2013 - US Equities - Source: Newswires